BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31018946)

  • 1. Gene Expression Comparison Between the Primary Tumor and its Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma: A Pilot Study.
    Karpathiou G; Stachowitz ML; Dumollard JM; Gavid M; Froudarakis M; Prades JM; Peoc'h M
    Cancer Genomics Proteomics; 2019; 16(3):155-161. PubMed ID: 31018946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomas.
    Bochen F; Adisurya H; Wemmert S; Lerner C; Greiner M; Zimmermann R; Hasenfus A; Wagner M; Smola S; Pfuhl T; Bozzato A; Al Kadah B; Schick B; Linxweiler M
    Oncotarget; 2017 Jan; 8(3):4922-4934. PubMed ID: 28002801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
    Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y
    Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of vascular endothelial growth factor family members in head and neck squamous cell carcinoma correlates with lymph node metastasis.
    O-charoenrat P; Rhys-Evans P; Eccles SA
    Cancer; 2001 Aug; 92(3):556-68. PubMed ID: 11505400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
    Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
    Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of microRNAs as markers for the detection of neck lymph node metastases in patients with head and neck squamous cell carcinoma.
    de Carvalho AC; Scapulatempo-Neto C; Maia DC; Evangelista AF; Morini MA; Carvalho AL; Vettore AL
    BMC Med; 2015 May; 13():108. PubMed ID: 25956054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-expression network-based identification of biomarkers correlated with the lymph node metastasis of patients with head and neck squamous cell carcinoma.
    Jin Y; Qin X
    Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32076707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of gene expression between metastatic derivatives and their poorly metastatic parental cells implicates crucial tumor-environment interaction in metastasis of head and neck squamous cell carcinoma.
    Chen Z; Zhang K; Zhang X; Yuan XH; Yuan Z; Jin L; Xiong M
    Clin Exp Metastasis; 2003; 20(4):335-42. PubMed ID: 12856721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survivin and pAkt as potential prognostic markers in squamous cell carcinoma of the head and neck.
    Pickhard A; Gröber S; Haug AK; Piontek G; Wirth M; Straßen U; Rudelius M; Reiter R
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jun; 117(6):733-42. PubMed ID: 24726415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and Prognostic Relevance of GAGE1 and XAGE1 Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma.
    Karia BTR; Zamuner FT; Carlin V; de Oliveira CZ; Carvalho AL; Vettore AL
    Curr Mol Med; 2017; 17(10):707-717. PubMed ID: 29577858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podoplanin is involved in the prognosis of head and neck squamous cell carcinoma through interaction with VEGF-C.
    Kim HY; Rha KS; Shim GA; Kim JH; Kim JM; Huang SM; Koo BS
    Oncol Rep; 2015 Aug; 34(2):833-42. PubMed ID: 26081937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas.
    Szabó B; Nelhubel GA; Kárpáti A; Kenessey I; Jóri B; Székely C; Peták I; Lotz G; Hegedus Z; Hegedus B; Füle T; Döme B; Tímár J; Tóvári J
    Oral Oncol; 2011 Jun; 47(6):487-96. PubMed ID: 21498106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
    Liu CJ; Liu TY; Kuo LT; Cheng HW; Chu TH; Chang KW; Lin SC
    J Pathol; 2008 Mar; 214(4):489-97. PubMed ID: 18213732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant Myosin 1b Expression Promotes Cell Migration and Lymph Node Metastasis of HNSCC.
    Ohmura G; Tsujikawa T; Yaguchi T; Kawamura N; Mikami S; Sugiyama J; Nakamura K; Kobayashi A; Iwata T; Nakano H; Shimada T; Hisa Y; Kawakami Y
    Mol Cancer Res; 2015 Apr; 13(4):721-31. PubMed ID: 25421751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases.
    Cortesina G; Martone T; Galeazzi E; Olivero M; De Stefani A; Bussi M; Valente G; Comoglio PM; Di Renzo MF
    Int J Cancer; 2000 May; 89(3):286-92. PubMed ID: 10861506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of tumor marker expression with nodal disease burden in metastatic head and neck cancer.
    Trivedi S; Mattos J; Gooding W; Godfrey TE; Ferris RL
    Otolaryngol Head Neck Surg; 2013 Aug; 149(2):261-8. PubMed ID: 23625795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression.
    Chung CH; Parker JS; Karaca G; Wu J; Funkhouser WK; Moore D; Butterfoss D; Xiang D; Zanation A; Yin X; Shockley WW; Weissler MC; Dressler LG; Shores CG; Yarbrough WG; Perou CM
    Cancer Cell; 2004 May; 5(5):489-500. PubMed ID: 15144956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EVI1 as a Marker for Lymph Node Metastasis in HNSCC.
    Idel C; Ribbat-Idel J; Kuppler P; Krupar R; Offermann A; Vogel W; Rades D; Kirfel J; Wollenberg B; Perner S
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations between prognosis and regional biomarker profiles in head and neck squamous cell carcinomas.
    Szentkúti G; Dános K; Brauswetter D; Kiszner G; Krenács T; Csákó L; Répássy G; Tamás L
    Pathol Oncol Res; 2015 Jul; 21(3):643-50. PubMed ID: 25547827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential imaging targets in primary head and neck squamous cell carcinoma and lymph node metastases.
    van Schaik JE; van der Vegt B; Slagter-Menkema L; Hanemaaijer SH; Halmos GB; Witjes MJH; van der Laan BFAM; Fehrmann RSN; Oosting SF; Plaat BEC
    Am J Otolaryngol; 2024; 45(4):104298. PubMed ID: 38640809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.